-+ 0.00%
-+ 0.00%
-+ 0.00%

What Analysts Are Saying About Labcorp Hldgs Stock

Benzinga·02/24/2026 18:00:56
Listen to the news

Across the recent three months, 4 analysts have shared their insights on Labcorp Hldgs (NYSE:LH), expressing a variety of opinions spanning from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 3 1 0 0
Last 30D 0 0 1 0 0
1M Ago 0 3 0 0 0
2M Ago 0 0 0 0 0
3M Ago 0 0 0 0 0

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $318.75, with a high estimate of $330.00 and a low estimate of $300.00. Witnessing a positive shift, the current average has risen by 4.59% from the previous average price target of $304.75.

price target chart

Breaking Down Analyst Ratings: A Detailed Examination

An in-depth analysis of recent analyst actions unveils how financial experts perceive Labcorp Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
David Westenberg Piper Sandler Raises Neutral $300.00 $270.00
Lisa Gill JP Morgan Raises Overweight $330.00 $319.00
Eric Coldwell Baird Raises Outperform $326.00 $313.00
Lisa Gill JP Morgan Raises Overweight $319.00 $317.00

Key Insights:

  • Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Labcorp Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Labcorp Hldgs compared to the broader market.
  • Price Targets: Gaining insights, analysts provide estimates for the future value of Labcorp Hldgs's stock. This comparison reveals trends in analysts' expectations over time.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Labcorp Hldgs's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Labcorp Hldgs analyst ratings.

All You Need to Know About Labcorp Hldgs

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Understanding the Numbers: Labcorp Hldgs's Finances

Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.

Revenue Growth: Labcorp Hldgs displayed positive results in 3M. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately 8.58%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Labcorp Hldgs's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.33% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.04%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): Labcorp Hldgs's ROA excels beyond industry benchmarks, reaching 1.44%. This signifies efficient management of assets and strong financial health.

Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.75, caution is advised due to increased financial risk.

Understanding the Relevance of Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.